Trial intelligence / Profile preview

Carbetocin vs Oxytocin for Postpartum Hemorrhage Prevention in Emergency Cesarean Section

NCT07380529Completed

Sponsor
Ankara Etlik City Hospital
Start
Oct 2024
Primary completion
Aug 2025
Modality
Peptides
Countries
1
01

Overview

Trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Ankara Etlik City Hospital. Primary endpoint: Postoperative change in hemoglobin at 24 hours. Started Oct 2024; status: completed.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT07380529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07380529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call